» Articles » PMID: 38396907

Autocrine Regulation of Interleukin-6 Via the Activation of STAT3 and Akt in Cardiac Myxoma Cells

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Feb 24
PMID 38396907
Authors
Affiliations
Soon will be listed here.
Abstract

Plasma concentrations of a pleiotropic cytokine, interleukin (IL)-6, are increased in patients with cardiac myxoma. We investigated the regulation of IL-6 in cardiac myxoma. Immunohistochemical staining and reverse transcription-polymerase chain reaction (RT-PCR) revealed that IL-6 and its receptors, IL-6 receptor (IL-6R) and gp130, co-existed in the myxoma cells. Myxoma cells were cultured, and an antibody array assay showed that a conditioned medium derived from the cultured myxoma cells contained increased amounts of IL-6. Signal transducer and activator of transcription (STAT) 3 and Akt were constitutively phosphorylated in the myxoma cells. An enzyme-linked immunosorbent assay (ELISA) showed that the myxoma cells spontaneously secreted IL-6 into the culture medium. Real-time PCR revealed that stimulation with IL-6 + soluble IL-6R (sIL6R) significantly increased IL-6 mRNA in the myxoma cells. Pharmacological inhibitors of STAT3 and Akt inhibited the IL-6 + sIL-6R-induced gene expression of IL-6 and the spontaneous secretion of IL-6. In addition, IL-6 + sIL-6R-induced translocation of phosphorylated STAT3 to the nucleus was also blocked by STAT3 inhibitors. This study has demonstrated that IL-6 increases its own production via STAT3 and Akt pathways in cardiac myxoma cells. Autocrine regulation of IL-6 may play an important role in the pathophysiology of patients with cardiac myxoma.

References
1.
Sakamoto H, Sakamaki T, Kanda T, Tsuchiya Y, Sato M, Sato H . Vascular endothelial growth factor is an autocrine growth factor for cardiac myxoma cells. Circ J. 2004; 68(5):488-93. DOI: 10.1253/circj.68.488. View

2.
Farzam-Kia N, Moratalla A, Lemaitre F, Levert A, Da Cal S, Margarido C . GM-CSF distinctly impacts human monocytes and macrophages via ERK1/2-dependent pathways. Immunol Lett. 2023; 261:47-55. DOI: 10.1016/j.imlet.2023.07.009. View

3.
Skamrov A, Nechaenko M, Goryunova L, Feoktistova E, Khaspekov G, Kovalevsky D . Gene expression analysis to identify mRNA markers of cardiac myxoma. J Mol Cell Cardiol. 2004; 37(3):717-33. DOI: 10.1016/j.yjmcc.2004.06.006. View

4.
Garcia-Zubiri C, Citores M, Yebra-Bango M . Contribution of monocytes to overproduction of interleukin-6 in a case of cardiac myxoma. Am J Med Sci. 2009; 338(4):336-7. DOI: 10.1097/MAJ.0b013e3181ab8a62. View

5.
Biswas P, Delfanti F, Bernasconi S, Mengozzi M, Cota M, Polentarutti N . Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line. Blood. 1998; 91(1):258-65. View